scorecard

You Searched For "Zydus Lifesciences market value" and got 15 results


Sort By:


Business Insider Latest Story Image
1 min read

Zydus Lifesciences acquires UK-based LiqMeds Group for GBP 68 million

LiqMeds Group of companies specialises in the development, manufacturing and supply of oral liq…

PTI   


Business Insider Latest Story Image
1 min read

Zydus Lifesciences Q1 2023-24 profit up 2-fold at Rs 1,087 cr

Revenue from operations during the quarter under review stood at Rs 5,139.6 crore as against Rs…

PTI   


Business Insider Latest Story Image
3 mins read

These are the companies that are making Remdesivir in India

Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…

Business Insider Latest Story Image
1 min read

Zydus Q4 net profit surges 4-fold to ₹1,182 cr; revenue at ₹5,534 cr

Revenue from operations rose to Rs 5,534 crore in the period under review from Rs 5,011 crore i…

PTI   


Business Insider Latest Story Image
2 mins read

These are the companies that are making Remdesivir in India

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

Business Insider Latest Story Image
2 mins read

Greenwich LifeSciences rockets 2,941% in a single day after encouraging phase 2 data on breast cancer treatment

Greenwich LifeSciences went public in September at an IPO price of $5.75, raising the firm $7.25 mi…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Supriya Lifescience IPO: Here’s how you can check the allotment status

The Mumbai-based active pharmaceuticals ingredients (APIs) manufacturer, Supriya Lifescience, is li…

Business Insider Latest Story Image
1 min read

Yes Bank sells over 16 lakh shares of Reliance Capital

New Delhi, Nov 25 () Yes Bank on Monday sold over 16 lakh shares of Reliance Capital for around Rs …

PTI   


Business Insider Latest Story Image
2 mins read

Cipla to sell anti-viral drug remdesivir as Cipremi in India

In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…

Business Insider Latest Story Image
2 mins read

Supriya Lifescience beats IPO investors expectations and debuts with 55% premium

The Mumbai-based active pharmaceutical ingredients (APIs) manufacturer, Supriya Lifescience made a …

Business Insider Latest Story Image
1 min read

Zydus Cadila gets USFDA nod to market ointment for treating skin conditions

The company has received final approval from the United States Food and Drug Administration (USFDA…

PTI   


Business Insider Latest Story Image
5 mins read

Analysts suggest subscribing to this pharma company IPO on discounted valuation and strong product portfolio than peers

Amid myriad initial public offerings (IPO) going on, here is another one worth giving attention to,…

Business Insider Latest Story Image
1 min read

Zydus Cadila gets USFDA nod to market cream for treating skin conditions

The final approval from the United States Food and Drug Administration (USFDA) is to market Fluoci…

PTI   


Business Insider Latest Story Image
1 min read

Zydus Cadila launches affordable oral anti-diabetic tablets in India as drug goes off patent

New Delhi, Dec 11 () Drug firm Zydus Cadila on Wednesday said it has launched its affordable oral a…

PTI   


Business Insider Latest Story Image
1 min read

Zydus Cadila gets final nod from USFDA to market generic seizures drug

The company has received final approval from the United States Food and Drug Administration (USFDA…

PTI